AngioDynamics Inc - Company Profile

Powered by

All the sales intelligence you need on AngioDynamics Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how AngioDynamics Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with AngioDynamics Inc.

Back to companies

AngioDynamics Inc: Segment Analysis

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Business Description

AngioDynamics Inc (AngioDynamics) designs, manufactures and markets minimal invasive and image-guided therapeutics and diagnostic devices for the treatment of peripheral vascular disease (PVD), tumors and other non-coronary diseases.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

R&D Overview

AngioDynamics' research and development activities focus on discovery and development of novel therapies and products and improving its existing product-lines. It focuses on clinical studies and research such as study of NanoKnife System for Ablation of Prostate Tissue, Clinical Study of Stage three Pancreatic Cancer. The company has R&D facility in Marlborough, Massachusetts. It conducts its R&D activities in vascular and oncology therapeutic areas. In FY2024, the company spent US$31.5 million on its R&D activities, which as a percentage of revenue stood at 10.4%, and grew 5.5% YoY.

Business Segments

Overview

Offers invasive peripheral products includes angiographic catheters, diagnostic and interventional guidewires, percutaneous drainage catheters and coaxial micro-introducer kits.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Overview

Offers Auryon Atherectomy System, thrombectomy devices, AngioVac, AlphaVac, thrombolytic catheters, and the NanoKnife IRE ablation system. It serves the vascular and oncology industries.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Subscribe for access to business segment analysis Subscribe for access to business segment analysis Learn more



Geographical Segments

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Gain a 360-degree view of AngioDynamics Inc and make more informed decisions for your business Gain a 360-degree view of AngioDynamics Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer